Will the FDA approve Ecstasy

The History of Ecstasy:

Ecstasy, XTC, or MDMA was first used in Germany in 1912. It was originally going to be used for a supplement to help people with extreme appetite. In the 1970’s, the drug was used for psychotherapy by a small group of therapists in the United States. Ecstasy did not become popular among Americans until the 1980s and 90s. It is commonly found at raves or rock concerts. Since the 1990’s, distribution of the drug has been spread steadily across America.

How it’s used:

 Ecstasy can be taken in a pill form, and is typically ingested through the mouth. However, it’s also a powder that can be snorted or smoked, but is hardly ever injected. Ecstasy can last anywhere from four to six hours, and typically produces feelings such as empathy for others, anxiety loss, very relaxed states, and positive “vibes”. This drug is so popular because people can party for days because of the drugs ability to rid people of the need to eat, sleep, or drink anything. This effect can cause severe dehydration and exhaustion. Fortunately, ecstasy is not as addictive as cocaine or heroin so is much less dangerous. The effects of ecstasy can start after just 20 minutes after consumption.

Short-Term Effects:

·         Blurred vision

·         Muscle Cramping

·         Chills and Sweating

·         Hallucinations

·         Tremors

Long-Term Effects:

·         Damage to the neurons in the brain

·         Permanent brain damage

Where it comes from:

Ecstasy has been created in many labs around the world, and more recently Israeli and Russian organizations have come together to manufacture the drug in many different forms to spread in the European countries. This is also a primary source for American distributors (dealers). Organizations from other countries have primary smuggled their products through the mail, but also commercial airlines and air freight shipments.

FDA’s role in the future of Ecstasy

                In Recent months, the FDA has approved a final trial of Molly on humans. The point of these trials is to hopefully find relief for people who suffer from PTSD. One study indicates that after three doses of MDMA, 56 percent of people suffering from PTSD reported a decrease in the severity of their symptoms, and follow-up exams indicated that the effects lasted for up to a year. Doctors fear people will abuse this drug, because thus far into the drugs history it’s just been used for partying and “feel good” experiences. The predictions of Ecstasy being approved by 2021 rely on these trials continuing to show improvement.